Assessing Benefits and Harms of Opioid Therapy for Chronic Pain
This is the third webinar in a COCA Call series about CDC Guideline for Prescribing Opioids for Chronic Pain. To view a list of other webinars in the series, visit the opioid call series overview webpage
Date:Wednesday, August 3, 2016
Deborah Dowell, MD, MPH
Senior Medical Advisor
Division of Unintentional Injury Prevention
National Center for Injury Control and Prevention
Centers for Disease Control and Prevention
Mark Sullivan, MD, PhD
Professor, Psychiatry and Behavioral Sciences
Anesthesiology and Pain Medicine
Bioethics and Humanities
University of Washington
Jane Ballantyne, MD, FRCA
Professor, Anesthesiology and Pain Medicine
Director, Pain Fellowship
University of Washington
Although evidence supports short-term effectiveness of opioids to treat pain, there is insufficient data that long-term use of opioids effectively treats chronic pain. In fact, long-term use of opioids in high doses can contribute to opioid-use disorder and overdose. Therefore, long-term opioid therapy should only be used when the benefits outweigh the risks. During this COCA Call, presenters will explore a case study on how recommendations from the CDC Guideline for Prescribing Opioids for Chronic Pain were used to ascertain the associated benefits and risks when a patient with fibromyalgia was prescribed oxycodone following a motor vehicle crash.
- Describe the evidence for the benefits and harms of opioid therapy for chronic pain outside of active cancer treatment, palliative, and end-of-life care.
- Review methods for setting goals for pain management with patients.
- Summarize factors that increase risk for harm and how to assess for such factors.
- Review methods for assessing patients’ pain and function, and for conducting appropriate follow-up.
CDC Guideline for Prescribing Opioids for Chronic Pain and Related Materials
- MMWR: CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
- JAMA Special Communication: CDC Guideline for Prescribing Opioids for Chronic PainExternal
- Guideline Resources: Clinical Tools
- Prescription Drug Monitoring Programs (PDMPs)Cdc-pdf
CDC Vital Signs
CDC Injury Prevention and Control
- CDC Prescription Drug Overdose
- Prescription Drug Overdose: What Health Care Providers Need to Know about the Epidemic
- Prescription Drug Overdose Prevention for States
Other Agency Resources
- The White House – Office of National Drug Control Policy: Opioid Abuse in the United StatesCdc-pdf[471KB]External
- NIH Pain Consortium Centers of Excellence in Pain Education (CoEPEs)External
- Providers’ Clinical Support System for Medication Assisted TreatmentExternal
- Providers’ Clinical Support System for Opioid TherapiesExternal
- CMS Improvements to Medicare Drug and Health PlansExternal
- SAMHSA – Substance Abuse and Mental Health Services AdministrationExternal
- National Institute on Drug AbuseExternal
- PDMP Center of Excellence, Brandeis UniversityExternal
- Audio conference call on 8/03/16: 2:00 – 3:00 PM EDT
- Web-on-demand training after 3:00 PM EDT on 8/03/16
- Materials: PowerPoint slide set
“WC2286” for attendees who participate in the live call (must be completed by September 2, 2016)
“WD2286” for attendees who participate in the online presentation (must be completed by September 2, 2018)
- Physician Assistants
- Health Educators
- Other Clinicians
- Contact Information:email@example.com
- Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communications Branch
- Method of Participation:You may participate in the educational activity by viewing the program information above.
- Fees:COCA continuing education credits are free.
CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides 1.0 contact hour.
IACET CEU:The Centers for Disease Control and Prevention is authorized by IACET to offer 1.0 CEU’s for this program.
CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designed for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-16-150-L04-P and enduring 0387-0000-16-150-H04-P course category.
Course Category: This activity has been designated as knowledge-based.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at firstname.lastname@example.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
CPH: The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.
CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.orgExternal.
There is no cost for this program.
DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Dr.Sullivan; he wishes to disclose that he is a consultant with Chrono Therapeutics concerning development and testing of an opioid taper device. The planning committee reviewed content to ensure there is no bias.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this continuing education activity.